Concepedia

Nagesh Jayaram

NJ

Statistics

Publications

5

Citations

262

H-Index

5

Active since

1992

Affiliations

Indiana University – Purdue University Indianapolis(Current)

Harvard University

UNC Lineberger Comprehensive Cancer Center

The University of Texas Southwestern Medical Center

Indiana University School of Medicine

Nagesh Jayaram is an author at Indiana University – Purdue University Indianapolis specializing in medicine, pharmacology, and chemotherapy.

Publications per year

1992–2023

5

Publications

5

Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer

Deborah Schrag, Hajime Uno, Rachel Rosovsky et al. · JAMA · 2023 · 141 citations · Full text

, , +17

Cytotoxicity of a new IMP dehydrogenase inhibitor, benzamide riboside, to human myelogenous leukemia K562 cells

Hiremagalur N. Jayaram, Kamran Gharehbaghi, Nagesh Jayaram et al. · Biochemical and Biophysical Research Communications · 1992 · 48 citations

, , +6

A randomized, double‐blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated extensive‐stage small cell lung cancer: Hoosier Cancer Research Network LUN06‐113

Rachel E. Sanborn, Jyoti D. Patel, Gregory A. Masters et al. · Cancer · 2016 · 26 citations · Full text

, , +15

The comparative effectiveness of direct oral anti-coagulants and low molecular weight heparins for prevention of recurrent venous thromboembolism in cancer: The CANVAS pragmatic randomized trial.

Deborah Schrag, Hajime Uno, Rachel Rosovsky et al. · Journal of Clinical Oncology · 2021 · 24 citations

, , +17

Nicotinamide mononucleotide adenylyltransferase2 overexpression enhances colorectal cancer cell-kill by Tiazofurin

Praveen Kusumanchi, Y. Zhang, Marghi Jani et al. · Cancer Gene Therapy · 2013 · 23 citations

, , +14

1–5 of 5